MAP Pharmaceuticals, Inc. — key financial figures for fiscal year 2011 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2011)

$23.1M

Net Income/Loss (FY2011)

-$260.5M

Total Assets (FY2011)

$107.3M

Total Equity (FY2011)

$39.6M

Cash Flows from Operating Activities (FY2011)

-$161.9M

Source: MAP Pharmaceuticals, Inc. 10-K filing (FY2011). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.